141 related articles for article (PubMed ID: 11124666)
1. Focal therapy in the management of retinoblastoma: when to start and when to stop.
Hamel P; Heon E; Gallie BL; Budning AS
J AAPOS; 2000 Dec; 4(6):334-7. PubMed ID: 11124666
[TBL] [Abstract][Full Text] [Related]
2. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
3. [Available approaches to retinoblastoma therapy--literature review].
Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
[TBL] [Abstract][Full Text] [Related]
4. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive method for repair of rhegmatogenous retinal detachment following treatment for retinoblastoma.
Buerk BM; Lai WW; Sharma MC; Shapiro MJ
Ophthalmic Surg Lasers Imaging; 2006; 37(1):82-5. PubMed ID: 16468560
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of large spot indirect ophthalmoscopy laser alone or combined with systemic chemotherapy in retinoblastoma therapy].
Liang JH; Cheng Y; Deng X; Yu YY; Li XX
Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):745-748. PubMed ID: 27760646
[TBL] [Abstract][Full Text] [Related]
7. Vitreoretinal complications of retinoblastoma treatment.
Tawansy KA; Samuel MA; Shammas M; Murphree AL
Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
[TBL] [Abstract][Full Text] [Related]
8. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
9. Thermotherapy for retinoblastoma.
Shields CL; Santos MC; Diniz W; Gündüz K; Mercado G; Cater JR; Shields JA
Arch Ophthalmol; 1999 Jul; 117(7):885-93. PubMed ID: 10408452
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.
Chawla B; Jain A; Seth R; Azad R; Mohan VK; Pushker N; Ghose S
Indian J Ophthalmol; 2016 Jul; 64(7):524-9. PubMed ID: 27609166
[TBL] [Abstract][Full Text] [Related]
11. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
[TBL] [Abstract][Full Text] [Related]
12. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
[TBL] [Abstract][Full Text] [Related]
13. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A
Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
[TBL] [Abstract][Full Text] [Related]
14. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine Green-Enhanced Transpupillary Thermotherapy for Retinoblastoma: Analysis of 42 Tumors.
Hasanreisoglu M; Saktanasate J; Schwendeman R; Shields JA; Shields CL
J Pediatr Ophthalmol Strabismus; 2015; 52(6):348-54. PubMed ID: 26584748
[TBL] [Abstract][Full Text] [Related]
16. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
17. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
18. Outcome of focal treatment to residual retinoblastoma after chemotherapy (Experience with Focal Treatment of Retinoblastoma).
Kashif S; Muhammad K; Siyal N; Adhi MI
J Pak Med Assoc; 2017 Jul; 67(7):1109-1115. PubMed ID: 28770899
[TBL] [Abstract][Full Text] [Related]
19. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.
Leng T; Cebulla CM; Schefler AC; Murray TG
Retina; 2010 Apr; 30(4 Suppl):S66-8. PubMed ID: 20419851
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the management of retinoblastoma.
Shields CL; Shields JA
J Pediatr Ophthalmol Strabismus; 1999; 36(1):8-18; quiz 35-6. PubMed ID: 9972509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
